Brian Higgins
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Melanoma and MAPK Pathways
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
Papers in
- Oncology 26
- Cancer-related Molecular Pathways 15
- Cytokine Signaling Pathways and Interactions 5
- HER2/EGFR in Cancer Research 4
-
- Melanoma and MAPK Pathways 7
- Angiogenesis and VEGF in Cancer 5
- PI3K/AKT/mTOR signaling in cancer 5
- Ubiquitin and proteasome pathways 4
- Co-authors
- Kathryn Packman (21 shared papers)Kenneth Kolinsky (18 shared papers)David Heimbrook (10 shared papers)Christian Tovar (11 shared papers)Zoran Filipovic (8 shared papers)James Rosinski (1 shared paper)Binh Thanh Vu (3 shared papers)Lyubomir T. Vassilev (2 shared papers)
- Journals
- Cancer Research (5 papers)Molecular Cancer Therapeutics (5 papers)Investigational New Drugs (3 papers)Journal of Clinical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Brian Higgins
38 papers receiving 2.9k citations
Brian Higgins's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 1.5k
- Molecular Biology 1.8k
- Cancer Research 351
- Biotechnology 170
- Hematology 151
Countries citing papers authored by Brian Higgins
This map shows the geographic impact of Brian Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Higgins more than expected).
Fields of papers citing papers by Brian Higgins
This network shows the impact of papers produced by Brian Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Higgins. The network helps show where Brian Higgins may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Higgins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy Hit paper breakdown → | 2006 | 556 |
| 2 | Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development Hit paper breakdown → | 2013 | 455 |
| 3 | 2010 | 308 | |
| 4 | 2020 | 287 | |
| 5 | 2011 | 171 | |
| 6 | 2004 | 127 | |
| 7 | 1998 | 116 | |
| 8 | 2017 | 84 | |
| 9 | 2004 | 82 | |
| 10 | 2013 | 69 | |
| 11 | 2011 | 62 | |
| 12 | 2014 | 58 | |
| 13 | 2012 | 53 | |
| 14 | 2014 | 50 | |
| 15 | 2014 | 45 | |
| 16 | 2014 | 42 | |
| 17 | 2006 | 42 | |
| 18 | 2011 | 39 | |
| 19 | 2011 | 36 | |
| 20 | 2009 | 34 |
About Brian Higgins
Brian Higgins is a scholar working on Oncology, Molecular Biology, Infectious Diseases, Genetics and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (15 papers), Melanoma and MAPK Pathways (7 papers), HIV/AIDS drug development and treatment (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Ubiquitin and proteasome pathways (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (1.5k citations), Molecular Biology (1.8k citations), Cancer Research (351 citations), Biotechnology (170 citations) and Hematology (151 citations). Brian Higgins has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Kathryn Packman, Kenneth Kolinsky, David Heimbrook, Christian Tovar, Zoran Filipovic, James Rosinski, Binh Thanh Vu, Lyubomir T. Vassilev, Xiaolan Zhao and Holly Hilton. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Investigational New Drugs, Journal of Clinical Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.